Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
Sanofi To Purchase Colombian Drug Firm
by Ann M. Thayer
October 8, 2012
| A version of this story appeared in
Volume 90, Issue 41
Sanofi has agreed to acquire Genfar, a 45-year-old pharmaceutical company based in Bogotá, Colombia. With sales of $133 million in 2011, Genfar produces generic, over-the-counter, and prescription drugs for human and animal health. Genfar is the second-largest generic drug company in Colombia, Sanofi says, and also does business in other Latin American countries. With $4.2 billion in sales in the region last year, Sanofi is the biggest multinational drug company in Latin America, according to Deutsche Bank.
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter